Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 4616

Sept 27 (Reuters) — An experimental Alzheimer’s drug made by Eisai Co Ltd (4523.T) and Biogen (BIIB.O) slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday, potentially a rare win in a field littered with failed drugs.

Multiple drugmakers have so far tried and failed to find an effective treatment for the brain-wasting disease that affects about 55 million people globally. A breakthrough would be a major boost to similar studies being run by Roche and Eli Lilly.

Speaking of the Eisai-Biogen drug results announced late on Tuesday night, Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center in Rochester, Minnesota said: “It’s not a huge effect, but it’s a positive effect”.

Read more | >

Researchers have used a novel near-infrared light imaging technique to capture the first cross-sectional images of carbon dioxide in the exhaust plume of a commercial jet engine. This new state-of-the-art technology could help accelerate turbine combustion research aimed at developing engines and aviation fuels that are more environmentally friendly.

“This approach, which we call chemical species tomography, provides spatially resolved information for from a large-scale commercial engine,” said research team leader Michael Lengden from the University of Strathclyde in the U.K. “This information has not been available before at this industrial scale and is a big improvement over the current industry-standard emissions measurement, which involves taking gas from the exhaust to a gas analyzer system in a different location.”

The researchers report the new research in Applied Optics. Chemical species tomography works much like the X-ray-based CT scans used in medicine, except that it uses near-infrared laser light tuned to the absorption wavelength of a target molecule and requires very fast imaging speeds to capture the dynamic processes of combustion.

Read more | >

The neurohormone oxytocin is well-known for promoting social bonds and generating pleasurable feelings, for example from art, exercise, or sex. But the hormone has many other functions, such as the regulation of lactation and uterine contractions in females, and the regulation of ejaculation, sperm transport, and testosterone production in males.

Now, researchers from Michigan State University show that in zebrafish and human cell cultures, oxytocin has yet another unsuspected function: It stimulates derived from the heart’s outer layer (epicardium) to migrate into its middle layer (myocardium) and there develop into cardiomyocytes, that generate heart contractions. This discovery could one day be used to promote the regeneration of the human heart after a . The results are published in Frontiers in Cell and Developmental Biology.

“Here we show that oxytocin, a neuropeptide also known as the love hormone, is capable of activating heart repair mechanisms in injured hearts in zebrafish and human cell cultures, opening the door to potential new therapies for heart regeneration in humans,” said Dr. Aitor Aguirre, an assistant professor at the Department of Biomedical Engineering of Michigan State University, and the study’s senior author.

Read more | >

Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here.

Cybercriminals are growing ever more relentless and deft with their attacks, with data breaches and system disruptions due to cyberattacks rising every year. Therefore, finding and strengthening cybersecurity weak spots, or vulnerabilities, is key to thwarting these attacks.

A key vulnerability is apps. Many organizations rely on productivity software and apps built in-house or from IT service providers to be competitive in today’s market. However, while these solutions boost productivity and employee and customer experiences, many of them have weak security measures that can expose the organization to cyberattackers.

Read more | >

Agility CEO Damion Shelton and CTO Jonathan Hurst discuss artificial intelligence and its role in robot control. They also discuss the capability of robot learning paired with physics-based locomotion, Cassie setting a new world record using learned policies for control, and an exploration of the future of robotics through Dall-E.

At Agility, we make robots that are made for work. Our robot Digit works alongside us in spaces designed for people. Digit handles the boring and repetitive tasks that are meant for a machine, which allows companies and their people to focus on the work that requires the human element.

Subscribe (hit the bell for notifications)

Join our Team.

Continue reading “Will Artificial Intelligence Drive Robots?” | >

Two milliseconds—or two thousandths of a second—is an extraordinarily long time in the world of quantum computing. On these timescales the blink of an eye—at one 10th of a second—is like an eternity.

Now a team of researchers at UNSW Sydney has broken new ground in proving that ‘spin qubits’—properties of electrons representing the basic units of information in quantum computers—can hold information for up to two milliseconds. Known as ‘coherence time’, the duration of time that qubits can be manipulated in increasingly complicated calculations, the achievement is 100 times longer than previous benchmarks in the same .

“Longer coherence time means you have more time over which your is stored—which is exactly what you need when doing quantum operations,” says Ph.D. student Ms Amanda Seedhouse, whose work in theoretical quantum computing contributed to the achievement.

Read more | >

Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here.

Modern software development typically follows a very iterative approach known as continuous integration/continuous development (CI/CD). The promise of CI/CD is better software that is released quicker and it’s a promise that ClearML now intends to bring to the world of machine learning (ML).

ClearML today announced the general availability of its enterprise MLops platform that extends the capabilities of the company’s open-source edition. The ClearML Enterprise platform provides organizations with security controls and additional capabilities for rapidly iterating and deploying ML workflows.

Read more | >

A new study by Zap Energy will assess the feasibility of siting a Zap fusion energy pilot plant at Washington’s only remaining coal power station.

Zap Energy will study the potential benefits of transitioning a natural gas power plant to a first-of-a-kind fusion pilot plant.

Read more | >